KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | +200.0% | 607 | +205.0% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 199 | -81.5% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 1,076 | -39.1% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 1,768 | -6.8% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 1,897 | +22.3% | 0.00% | -100.0% |
| Q2 2021 | $16,000 | +6.7% | 1,551 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $15,000 | -11.8% | 1,454 | +32.2% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +750.0% | 1,100 | +558.7% | 0.00% | – |
| Q3 2020 | $2,000 | -60.0% | 167 | -39.9% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 278 | +56.2% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 178 | -32.1% | 0.00% | – |
| Q4 2019 | $5,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |